Prof. Dimitrios Farmakis

National and Kapodistrian University of Athens, Greece

E-mail: dimitrios_farmakis@yahoo.com

Qualifications

2003  PhD, University of Athens Medical School

1996  MD, University of Athens Medical School

Publications (Selected)

1. Theofilis, P., Leontsinis, I., Farmakis, D., Avramidis, D., Argyriou, N., Didagelos, M., ... & Tsioufis, K. (2025). Trends in Utilization of Guideline-Directed Cardiorenal Protective Therapies for Chronic Kidney Disease in Patients with Cardiovascular Morbidity: Real World Data from Two Cross-Sectional Snapshots (HECMOS I and II). Biomedicines, 13(8), 1987.
2. Samaras, A., Papazoglou, A. S., Moysidis, D. V., Bekiaridou, A., Tsoumakas, G., Tzikas, A., ... & Theofilatos, A. (2025). Clinical profiles and temporal trends of 37,741 cardiovascular hospitalizations in Greece over 12 years: initial insights from the CardioMining database. Hellenic Journal of Cardiology.
3. Chioncel, O., Mebazaa, A., Farmakis, D., Abdelhamid, M., Lund, L. H., Harjola, V. P., ... & Metra, M. (2025). Pathophysiology and clinical use of agents with vasodilator properties in acute heart failure. A scientific statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). European Journal of Heart Failure.
4. Ghigo, A., Ameri, P., Asnani, A., Bertero, E., de Boer, R. A., Farmakis, D., ... & Van Linthout, S. (2025). Update on preclinical models of cancer therapy‐related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio‐Oncology, and the ESC Working Group on Cellular Biology of the Heart. European journal of heart failure.
5. Bistola, V., Farmakis, D., Tromp, J., Tay, W. T., Ouwerkerk, W., Angermann, C. E., ... & Filippatos, G. (2025). Hospitalized advanced heart failure with preserved vs reduced left ventricular ejection fraction: a global perspective. Heart Failure, 13(2), 229-247.
6. Zouganeli, V., Kourek, C., Bistola, V., Mademli, M., Grigoropoulos, I., Thomas, K., ... & Farmakis, D. (2024). Campylobacter jejuni-related myocarditis: a case report and review of the literature. Journal of Clinical Medicine, 13(24), 7551.
7. Paraskevaidis, I., Kourek, C., Farmakis, D., & Tsougos, E. (2024). Mitochondrial dysfunction in cardiac disease: the fort fell. Biomolecules, 14(12), 1534.
8. Farmakis, D., Davison, B., Fountoulaki, K., Liori, S., Chioncel, O., Metra, M., ... & Filippatos, G. (2024). Rapid uptitration of guideline-directed medical therapies in acute heart failure with and without atrial fibrillation. Heart Failure, 12(11), 1845-1858.
9. Keramida, K., Farmakis, D., Rakisheva, A., Tocchetti, C. G., Ameri, P., Asteggiano, R., ... & Rosano, G. (2024). The right heart in patients with cancer. A scientific statement of the heart failure association (HFA) of the ESC and the ESC Council of cardio‐oncology. European Journal of Heart Failure, 26(10), 2077-2093.
10. Tocchetti, C. G., Farmakis, D., Koop, Y., Andres, M. S., Couch, L. S., Formisano, L., ... & Lyon, A. R. (2024). Cardiovascular toxicities of immune therapies for cancer–a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio‐Oncology. European Journal of Heart Failure, 26(10), 2055-2076.
11. Farmakis, D., Hermann, J., Lyon, A. R., & López-Fernández, T. (2024). Education in cardio-oncology: the next frontiers.
12. Farmakis, D., & Filippatos, G. (2024). Cancer begets atrial fibrillation… and vice versa?. European Heart Journal, 45(25), 2214-2216.
13. Manta, E., Thomopoulos, C., Kariori, M., Polyzos, D., Mihas, C., Konstantinidis, D., ... & Tsioufis, K. (2024). Revisiting Cardiovascular Benefits of Blood Pressure Reduction in Primary and Secondary Prevention: Focus on Targets and Residual Risk—A Systematic Review and Meta-Analysis. Hypertension, 81(5), 1076-1086.
14. López‐Fernández, T., Farmakis, D., Ameri, P., Asteggiano, R., de Azambuja, E., Aznar, M., ... & Rosano, G. M. (2024). European Society of Cardiology Core Curriculum for c ardio‐oncology. European journal of heart failure, 26(4), 754-771.
15. Kourek, C., Briasoulis, A., Papamichail, A., Xanthopoulos, A., Tsougos, E., Farmakis, D., & Paraskevaidis, I. (2024). Beyond Quadruple Therapy and Current Therapeutic Strategies in Heart Failure with Reduced Ejection Fraction: Medical Therapies with Potential to Become Part of the Therapeutic Armamentarium. International Journal of Molecular Sciences, 25(6), 3113.
16. Adamo, M., Chioncel, O., Pagnesi, M., Bayes‐Genis, A., Abdelhamid, M., Anker, S. D., ... & Metra, M. (2024). Epidemiology, pathophysiology, diagnosis and management of chronic right‐sided heart failure and tricuspid regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC. European journal of heart failure, 26(1), 18-33.

Profile Details

WoS ResearcherID: AAK-4509-2020

https://orcid.org/0000-0001-8364-3447

https://www.ucy.ac.cy/directory/en/profile/dfarma01

https://scholar.google.com/citations?user=01v5-U0AAAAJ&hl=en